PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930138
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930138
Genetic Testing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
Growth Factors of genetic testing Market
The global genetic testing market has emerged as a critical pillar of modern healthcare, driven by rapid advances in molecular biology, rising disease prevalence, and growing adoption of personalized medicine. According to Fortune Business Insights, the market was valued at USD 37.32 billion in 2025 and is projected to grow from USD 41.22 billion in 2026 to USD 93.94 billion by 2034, registering a CAGR of 10.85% during the forecast period.
In 2025, North America dominated the market with a 41.67% share, supported by strong healthcare infrastructure, technological leadership, and high awareness of genetic testing benefits.
Market Definition and Scope
Genetic testing involves the analysis of DNA, chromosomes, or proteins to detect genetic mutations or variations that may cause or increase the risk of inherited disorders. These tests are widely used for disease diagnosis, risk assessment, treatment planning, and preventive healthcare. The market comprises products (equipment and consumables) and services, catering to applications such as oncology, prenatal testing, pharmacogenomics, cardiology, and others.
Market Drivers
Rising Prevalence of Chronic and Genetic Disorders
The increasing burden of chronic and genetic diseases such as cancer, diabetes, sickle cell disease, cystic fibrosis, and Down syndrome is a major driver of market growth. According to global health estimates, the number of individuals living with sickle cell disease rose significantly between 2000 and 2021, highlighting the growing need for early and accurate genetic diagnosis. Additionally, the rising elderly population, sedentary lifestyles, and tobacco exposure are contributing to higher disease incidence, thereby boosting demand for genetic testing.
Surge in New Product Launches
Continuous innovation and frequent launches of advanced diagnostic tests are accelerating market expansion. Companies are increasingly introducing high-precision tests for oncology, cardiology, and infectious diseases. Strategic mergers, acquisitions, and geographic expansion by leading players further strengthen market growth during the forecast period.
Market Restraints
Shortage of Skilled Professionals
A key restraining factor is the shortage of skilled laboratory technologists, especially in emerging economies. Limited access to advanced equipment, insufficient training, and inadequate laboratory infrastructure restrict the effective adoption of genetic testing services, posing challenges to market growth.
Market Opportunities
Digitalization and EHR Integration
The integration of genetic testing data with Electronic Health Records (EHRs) presents a significant growth opportunity. Digital decision-support tools, AI-enabled analytics, and genetic counseling chatbots are streamlining workflows and improving clinical decision-making. Collaborations between diagnostic companies and EHR vendors enable seamless test ordering and result interpretation, enhancing patient outcomes.
Market Challenges
Regulatory and Ethical Concerns
The genetic testing market faces complex regulatory and ethical challenges related to data privacy, informed consent, and potential genetic discrimination. Regulatory frameworks vary significantly across regions, creating compliance complexities for manufacturers and service providers. Additionally, despite declining test costs, high out-of-pocket expenses continue to limit adoption in cost-sensitive markets.
Market Trends
Shift Toward At-Home and DTC Testing
One of the most prominent trends is the growing adoption of at-home and direct-to-consumer (DTC) genetic testing kits. Increased awareness of preventive healthcare and advancements in testing technologies have fueled demand for affordable, convenient testing solutions. Integration of genetic data into EHR systems and the rise of personalized medicine further support this trend.
Segmentation Analysis
- By Type: The services segment dominated the market due to the rising number of diagnostic laboratories worldwide. The product segment, contributing 48.81% globally in 2026, benefits from increased testing volumes and frequent consumable usage.
- By Technique: Next-Generation Sequencing (NGS) holds the largest share owing to its high accuracy and suitability for precision medicine. The PCR segment accounts for 46.0% market share in 2026, driven by widespread clinical adoption.
- By Application: The oncology segment dominated with a 55.63% share in 2026, supported by the rising prevalence of cancer and demand for early diagnosis.
Regional Outlook
- North America: Valued at USD 15.55 billion in 2025, with the U.S. market reaching USD 15.64 billion in 2026.
- Europe: Moderate growth supported by R&D investments; Germany and the UK remain key contributors.
- Asia Pacific: Expected to grow at the highest CAGR, with China, Japan, and India showing strong expansion due to government precision-medicine initiatives.
- Latin America & Middle East & Africa: Gradual growth driven by healthcare investments and improving diagnostic access.
Competitive Landscape
The market is partially consolidated, with major players including Hoffmann-La Roche Ltd., Illumina, Inc., QIAGEN, and Quest Diagnostics Incorporated. These companies focus on innovation, strategic collaborations, and portfolio expansion to maintain competitive advantage.
Conclusion
In conclusion, the global genetic testing market is set for robust growth from USD 37.32 billion in 2025 to USD 93.94 billion by 2034, driven by technological advancements, rising disease prevalence, and increasing adoption of personalized medicine. While regulatory complexities and workforce shortages pose challenges, ongoing innovation, digital integration, and expanding healthcare access are expected to sustain long-term market expansion and transform the future of precision diagnostics.
Segmentation By Type
- Products
- Equipment
- Consumables
- Services
By Technique
- Next-generation Sequencing (NGS)
- Polymerase Chain Reaction
- Microarrays
- In-situ Hybridization
- Others
By Application
- Oncology
- Prenatal Testing
- Pharmacogenomics
- Cardiology
- Others
By Region
- North America (By Type, Technique, Application, and Country)
- U.S.
- Canada
- Europe (By Type, Technique, Application, and Country/Sub-region)
- U.K.
- Germany
- France
- Spain
- Italy
- Scandinavia
- Rest of Europe
- Asia Pacific (By Type, Technique, Application, and Country/Sub-region)
- Japan
- China
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
- Latin America (By Type, Technique, Application, and Country/Sub-region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Type, Technique, Application, and Country/Sub-region)
- GCC
- South Africa
- Rest of the Middle East & Africa
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Prevalence of Key Diseases, By Key Countries, 2025
- 4.2. New Product Launches/ Approvals, By Key Players
- 4.3. Key Industry Developments- Mergers, Partnerships, Acquisitions, etc.
- 4.4. Impact of COVID-19 on the Market
5. Global Genetic Testing Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Type
- 5.1.1. Products
- 5.1.1.1. Equipment
- 5.1.1.2. Consumables
- 5.1.2. Services
- 5.1.1. Products
- 5.2. Market Analysis, Insights and Forecast - By Technique
- 5.2.1. Next-generation Sequencing (NGS)
- 5.2.2. Polymerase Chain Reaction
- 5.2.3. Microarrays
- 5.2.4. In-situ Hybridization
- 5.2.5. Others
- 5.3. Market Analysis, Insights and Forecast - By Application
- 5.3.1. Oncology
- 5.3.2. Prenatal Testing
- 5.3.3. Pharmacogenomics
- 5.3.4. Cardiology
- 5.3.5. Others
- 5.4. Market Analysis, Insights and Forecast - By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
6. North America Genetic Testing Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Type
- 6.1.1. Products
- 6.1.1.1. Equipment
- 6.1.1.2. Consumables
- 6.1.2. Services
- 6.1.1. Products
- 6.2. Market Analysis, Insights and Forecast - By Technique
- 6.2.1. Next-generation Sequencing (NGS)
- 6.2.2. Polymerase Chain Reaction
- 6.2.3. Microarrays
- 6.2.4. In-situ Hybridization
- 6.2.5. Others
- 6.3. Market Analysis, Insights and Forecast - By Application
- 6.3.1. Oncology
- 6.3.2. Prenatal Testing
- 6.3.3. Pharmacogenomics
- 6.3.4. Cardiology
- 6.3.5. Others
- 6.4. Market Analysis, Insights and Forecast - By Country
- 6.4.1. U.S.
- 6.4.2. Canada
7. Europe Genetic Testing Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Type
- 7.1.1. Products
- 7.1.1.1. Equipment
- 7.1.1.2. Consumables
- 7.1.2. Services
- 7.1.1. Products
- 7.2. Market Analysis, Insights and Forecast - By Technique
- 7.2.1. Next-generation Sequencing (NGS)
- 7.2.2. Polymerase Chain Reaction
- 7.2.3. Microarrays
- 7.2.4. In-situ Hybridization
- 7.2.5. Others
- 7.3. Market Analysis, Insights and Forecast - By Application
- 7.3.1. Oncology
- 7.3.2. Prenatal Testing
- 7.3.3. Pharmacogenomics
- 7.3.4. Cardiology
- 7.3.5. Others
- 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 7.4.1. Germany
- 7.4.2. U.K.
- 7.4.3. France
- 7.4.4. Italy
- 7.4.5. Spain
- 7.4.6. Scandianvia
- 7.4.7. Rest of Europe
8. Asia Pacific Genetic Testing Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Type
- 8.1.1. Products
- 8.1.1.1. Equipment
- 8.1.1.2. Consumables
- 8.1.2. Services
- 8.1.1. Products
- 8.2. Market Analysis, Insights and Forecast - By Technique
- 8.2.1. Next-generation Sequencing (NGS)
- 8.2.2. Polymerase Chain Reaction
- 8.2.3. Microarrays
- 8.2.4. In-situ Hybridization
- 8.2.5. Others
- 8.3. Market Analysis, Insights and Forecast - By Application
- 8.3.1. Oncology
- 8.3.2. Prenatal Testing
- 8.3.3. Pharmacogenomics
- 8.3.4. Cardiology
- 8.3.5. Others
- 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 8.4.1. China
- 8.4.2. India
- 8.4.3. Japan
- 8.4.4. South Korea
- 8.4.5. Southeast Asia
- 8.4.6. Rest of Asia Pacific
9. Latin America Genetic Testing Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Type
- 9.1.1. Products
- 9.1.1.1. Equipment
- 9.1.1.2. Consumables
- 9.1.2. Services
- 9.1.1. Products
- 9.2. Market Analysis, Insights and Forecast - By Technique
- 9.2.1. Next-generation Sequencing (NGS)
- 9.2.2. Polymerase Chain Reaction
- 9.2.3. Microarrays
- 9.2.4. In-situ Hybridization
- 9.2.5. Others
- 9.3. Market Analysis, Insights and Forecast - By Application
- 9.3.1. Oncology
- 9.3.2. Prenatal Testing
- 9.3.3. Pharmacogenomics
- 9.3.4. Cardiology
- 9.3.5. Others
- 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
10. Middle East & Africa Genetic Testing Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Type
- 10.1.1. Products
- 10.1.1.1. Equipment
- 10.1.1.2. Consumables
- 10.1.2. Services
- 10.1.1. Products
- 10.2. Market Analysis, Insights and Forecast - By Technique
- 10.2.1. Next-generation Sequencing (NGS)
- 10.2.2. Polymerase Chain Reaction
- 10.2.3. Microarrays
- 10.2.4. In-situ Hybridization
- 10.2.5. Others
- 10.3. Market Analysis, Insights and Forecast - By Application
- 10.3.1. Oncology
- 10.3.2. Prenatal Testing
- 10.3.3. Pharmacogenomics
- 10.3.4. Cardiology
- 10.3.5. Others
- 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 10.4.1. GCC
- 10.4.2. South Africa
- 10.4.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. Hoffmann-La Roche Ltd.
- 11.2.1.1. Overview
- 11.2.1.2. Products & services
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. Illumina, Inc.
- 11.2.2.1. Overview
- 11.2.2.2. Products & services
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. Thermo Fisher Scientific Inc.
- 11.2.3.1. Overview
- 11.2.3.2. Products & services
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. Bio-Rad Laboratories, Inc
- 11.2.4.1. Overview
- 11.2.4.2. Products & services
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. Oxford Nanopore Technologies plc.
- 11.2.5.1. Overview
- 11.2.5.2. Products & services
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. Laboratory Corporation of America Holdings
- 11.2.6.1. Overview
- 11.2.6.2. Products & services
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. Agilent Technologies, Inc.
- 11.2.7.1. Overview
- 11.2.7.2. Products & services
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. Myriad Genetics, Inc.
- 11.2.8.1. Overview
- 11.2.8.2. Products & services
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.9. QIAGEN
- 11.2.9.1. Overview
- 11.2.9.2. Products & services
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Strategies
- 11.2.9.6. Financials (Based on Availability)
- 11.2.10. Quest Diagnostics Incorporated.
- 11.2.10.1. Overview
- 11.2.10.2. Products & services
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Strategies
- 11.2.10.6. Financials (Based on Availability)
- 11.2.11. Danaher Corporation
- 11.2.11.1. Overview
- 11.2.11.2. Products & services
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Strategies
- 11.2.11.6. Financials (Based on Availability)
- 11.2.1. Hoffmann-La Roche Ltd.
List of Tables
- Table 1: Global Genetic Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 2: Global Genetic Testing Market Revenue (USD billion) Forecast, by Products, 2021-2034
- Table 3: Global Genetic Testing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
- Table 4: Global Genetic Testing Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 5: Global Genetic Testing Market Revenue (USD billion) Forecast, by Region, 2021-2034
- Table 6: North America Genetic Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 7: North America Genetic Testing Market Revenue (USD billion) Forecast, by Products, 2021-2034
- Table 8: North America Genetic Testing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
- Table 9: North America Genetic Testing Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 10: North America Genetic Testing Market Revenue (USD billion) Forecast, By Country, 2021-2034
- Table 11: Europe Genetic Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 12: Europe Genetic Testing Market Revenue (USD billion) Forecast, by Products, 2021-2034
- Table 13: Europe Genetic Testing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
- Table 14: Europe Genetic Testing Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 15: Europe Genetic Testing Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034
- Table 16: Asia Pacific Genetic Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 17: Asia Pacific Genetic Testing Market Revenue (USD billion) Forecast, by Products, 2021-2034
- Table 18: Asia Pacific Genetic Testing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
- Table 19: Asia Pacific Genetic Testing Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 20: Asia Pacific Genetic Testing Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 21: Latin America Genetic Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 22: Latin America Genetic Testing Market Revenue (USD billion) Forecast, by Products 2021-2034
- Table 23: Latin America Genetic Testing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
- Table 24: Latin America Genetic Testing Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 25: Latin America Genetic Testing Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 26: Middle East & Africa Genetic Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 27: Middle East & Africa Genetic Testing Market Revenue (USD billion) Forecast, by Products, 2021-2034
- Table 28: Middle East & Africa Genetic Testing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
- Table 29: Middle East & Africa Genetic Testing Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 30: Middle East & Africa Genetic Testing Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
List of Figures
- Figure 1: Global Genetic Testing Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
- Figure 2: Global Genetic Testing Market Value Share (%), by Type, 2025 & 2034
- Figure 3: Global Genetic Testing Market Value Share (%), by Technique, 2025 & 2034
- Figure 4: Global Genetic Testing Market Value Share (%), by Application, 2025 & 2034
- Figure 5: Global Genetic Testing Market Value (USD billion), by Region, 2025 & 2034
- Figure 6: North America Genetic Testing Market Value (USD billion), by Type, 2025 & 2034
- Figure 7: North America Genetic Testing Market Value Share (%), by Type, 2025
- Figure 8: North America Genetic Testing Market Value (USD billion), by Technique, 2025 & 2034
- Figure 9: North America Genetic Testing Market Value Share (%), by Technique, 2025
- Figure 10: North America Genetic Testing Market Value (USD billion), by Application, 2025 & 2034
- Figure 11: North America Genetic Testing Market Value Share (%), by Application, 2025
- Figure 12: North America Genetic Testing Market Value (USD billion), By Country, 2025 & 2034
- Figure 13: North America Genetic Testing Market Value Share (%), By Country, 2025
- Figure 14: Europe Genetic Testing Market Value (USD billion), by Type, 2025 & 2034
- Figure 15: Europe Genetic Testing Market Value Share (%), by Type, 2025
- Figure 16: Europe Genetic Testing Market Value (USD billion), by Technique, 2025 & 2034
- Figure 17: Europe Genetic Testing Market Value Share (%), by Technique, 2025
- Figure 18: Europe Genetic Testing Market Value (USD billion), by Application, 2025 & 2034
- Figure 19: Europe Genetic Testing Market Value Share (%), by Application, 2025
- Figure 20: Europe Genetic Testing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 21: Europe Genetic Testing Market Value Share (%), By Country/ Sub-region, 2025
- Figure 22: Asia Pacific Genetic Testing Market Value (USD billion), by Type, 2025 & 2034
- Figure 23: Asia Pacific Genetic Testing Market Value Share (%), by Type, 2025
- Figure 24: Asia Pacific Genetic Testing Market Value (USD billion), by Technique, 2025 & 2034
- Figure 25: Asia Pacific Genetic Testing Market Value Share (%), by Technique, 2025
- Figure 26: Asia Pacific Genetic Testing Market Value (USD billion), by Application, 2025 & 2034
- Figure 27: Asia Pacific Genetic Testing Market Value Share (%), by Application, 2025
- Figure 28: Asia Pacific Genetic Testing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 29: Asia Pacific Genetic Testing Market Value Share (%), By Country/ Sub-region, 2025
- Figure 30: Latin America Genetic Testing Market Value (USD billion), by Type, 2025 & 2034
- Figure 31: Latin America Genetic Testing Market Value Share (%), by Type, 2025
- Figure 32: Latin America Genetic Testing Market Value (USD billion), by Technique, 2025 & 2034
- Figure 33: Latin America Genetic Testing Market Value Share (%), by Technique, 2025
- Figure 34: Latin America Genetic Testing Market Value (USD billion), by Application, 2025 & 2034
- Figure 35: Latin America Genetic Testing Market Value Share (%), by Application, 2025
- Figure 36: Latin America Genetic Testing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 37: Latin America Genetic Testing Market Value Share (%), By Country/ Sub-region, 2025
- Figure 38: Middle East & Africa Genetic Testing Market Value (USD billion), by Type, 2025 & 2034
- Figure 39: Middle East & Africa Genetic Testing Market Value Share (%), by Type, 2025
- Figure 40: Middle East & Africa Genetic Testing Market Value (USD billion), by Technique, 2025 & 2034
- Figure 41: Middle East & Africa Genetic Testing Market Value Share (%), by Technique, 2025
- Figure 42: Middle East & Africa Genetic Testing Market Value (USD billion), by Application, 2025 & 2034
- Figure 43: Middle East & Africa Genetic Testing Market Value Share (%), by Application, 2025
- Figure 44: Middle East & Africa Genetic Testing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 45: Middle East & Africa Genetic Testing Market Value Share (%), By Country/ Sub-region, 2025
- Figure 46: Global Genetic Testing Market Share (%), By Company, 2025
